Applications Now Open: ALLG HSANZ Clinical Trials Fellowship 2026

If you're an early-career clinician or researcher passionate about advancing blood cancer research, the Australasian Leukaemia & Lymphoma Group (ALLG), in partnership with the Haematology Society of Australia and New Zealand (HSANZ), invites you to apply for the 2026 ALLG HSANZ Clinical Trials Fellowship. This prestigious program offers a unique opportunity to engage in investigator-initiated clinical trials, contributing to the development of better treatments and improved patient outcomes.

---

🗒️ Fellowship Summary

• Location: Australia and New Zealand

• Host Institutions: Australasian Leukaemia & Lymphoma Group (ALLG) and Haematology Society of Australia and New Zealand (HSANZ)

• Academic Level: Postgraduate (Early-career clinicians and researchers)

• Target Group: Early-career professionals in haematology and related fields

• Fields of Focus: Clinical trials and translational research in blood cancers (e.g., leukaemia, lymphoma, myeloma)

• Value and Coverage: AUD 70,000 (inclusive of stipend and consumables)

• Duration: 12 months

• Application Deadline: Sunday, 27 July 2025, at 11:59 PM

• Start Date: 2026

• Eligible To: Early-career clinicians and researchers with a focus on haematology

---

🎓 Fellowship Overview

The ALLG HSANZ Clinical Trials Fellowship is designed to nurture the next generation of blood cancer researchers by providing hands-on experience in clinical trial design, implementation, and analysis. Fellows will work closely with leading experts, gaining valuable skills and networks to drive investigator-initiated clinical trials across various blood cancers.

The program supports projects aligned with ALLG's Scientific Research Strategy Pillars and HSANZ's purpose, aiming to deliver better outcomes for patients through innovative research.

---

🎁 Fellowship Benefits

• Financial Support: AUD 70,000 funding over 12 months, covering stipend and consumables.

• Professional Development: Opportunity to collaborate with leading haematology experts and participate in cutting-edge clinical trials.

• Research Impact: Contribute to meaningful research that has the potential to improve treatments and patient care in blood cancers.

---

✅ Eligibility Criteria

To be considered for ALLG HSANZ Clinical Trials Fellowship, Applicants must:

1. Be early-career clinicians or researchers with a demonstrated interest in haematology.

2. Propose a specific project in clinical trial and/or translational research in blood cancer.

3. Be prepared to commence the fellowship in 2026.

---

📝 Application Procedure

1. Visit the [HSANZ Scholarships and Awards page] for detailed information and application forms.

2. Prepare the following documents:

• A detailed research proposal outlining the clinical trial or translational research project.

• Curriculum Vitae (CV) highlighting relevant experience and qualifications.

• Letters of support or references from supervisors or mentors.

3. Submit your application by the deadline: Sunday, 27 July 2025, at 11:59 PM.

🔗 OFFICIAL LINK

2026 ALLG HSANZ Clinical Trials Fellowship

---